Biofrontera (BFRI) to Release Earnings on Friday

Biofrontera (NASDAQ:BFRI) is projected to announce its earnings results before the market opens on Friday, March 21st. Analysts expect the company to announce earnings of $0.02 per share and revenue of $14.53 million for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Biofrontera Stock Performance

BFRI opened at $1.00 on Thursday. Biofrontera has a twelve month low of $0.65 and a twelve month high of $2.43. The firm has a market cap of $7.75 million, a PE ratio of -0.44 and a beta of 0.30. The firm’s fifty day moving average is $1.05 and its two-hundred day moving average is $1.03.

Biofrontera Company Profile

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.